BACKGROUND: Intraoperative measurements of left ventricular (LV) pacing and sensing values were assessed using a novel 0.014-inch guidewire (Visionwire, Biotronik GmbH, Berlin, Germany) enabling pacing and sensing at the distal tip before final LV lead implantation. METHODS: Twenty-two consecutive patients selected for cardiac resynchronization therapy were studied. RESULTS: Significant correlation was found between the LV pacing threshold as assessed by the Visionwire and values after final LV lead implantation (r = 0.92, P < 0.001). Correlation for LV sensing was also significant (r = 0.72, P < 0.001). No significant correlation was present with respect to phrenic nerve stimulation. However, no phrenic nerve stimulation at 10 V/0.5 ms using the Visionwire identified 88% of patients without phrenic nerve stimulation at 10 V/0.5 ms with subsequent LV lead measurements. CONCLUSION: This technique may facilitate transvenous LV lead implantation by preventing implantation in a unsuitable target vessel with respect to pacing and sensing values or phrenic nerve stimulation, thereby reducing procedure and fluoroscopy time.
BACKGROUND: Intraoperative measurements of left ventricular (LV) pacing and sensing values were assessed using a novel 0.014-inch guidewire (Visionwire, Biotronik GmbH, Berlin, Germany) enabling pacing and sensing at the distal tip before final LV lead implantation. METHODS: Twenty-two consecutive patients selected for cardiac resynchronization therapy were studied. RESULTS: Significant correlation was found between the LV pacing threshold as assessed by the Visionwire and values after final LV lead implantation (r = 0.92, P < 0.001). Correlation for LV sensing was also significant (r = 0.72, P < 0.001). No significant correlation was present with respect to phrenic nerve stimulation. However, no phrenic nerve stimulation at 10 V/0.5 ms using the Visionwire identified 88% of patients without phrenic nerve stimulation at 10 V/0.5 ms with subsequent LV lead measurements. CONCLUSION: This technique may facilitate transvenous LV lead implantation by preventing implantation in a unsuitable target vessel with respect to pacing and sensing values or phrenic nerve stimulation, thereby reducing procedure and fluoroscopy time.